Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 14, 2026Aug 18 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
3,664$114.49$419.5K9,755(D)

View →

Aug 14, 2026Aug 18 8:30 PMJames N WilsonDirector
Sale
10,000$111.43$1.1M1,074,543(I)

View →

Aug 17, 2026Aug 18 8:30 PMGary Charles RobbChief Business Officer
Sale
10,000$116.26$1.2M39,716(I)

View →

Aug 18, 2026Aug 18 2:12 PMMAHONEY DAVID L
Proposed Sale
103,606$117.37$12.2M—

View →

Aug 17, 2026Aug 17 8:05 PMRobb Gary Charles
Proposed Sale
10,000$116.26$1.2M—

View →

Aug 10, 2026Aug 12 8:27 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
1,031$114.52$118.1K9,755(D)

View →

Aug 10, 2026Aug 12 8:26 PMWilliam GuyerChief Development Officer
Sale
16,300$113.43$1.8M3,985(D)

View →

Aug 4, 2026Aug 6 10:44 PMWilliam GuyerChief Development Officer
Sale
3,700$113.12$418.6K3,985(D)

View →

Aug 3, 2026Aug 5 9:51 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
20,305$114.70$2.3M9,755(D)

View →

Aug 3, 2026Aug 5 9:48 PMJoseph Douglas LyonChief Accounting & Technology Officer
Sale
1,540$114.16$175.8K5,495(D)

View →

Aug 4, 2026Aug 4 7:07 PMGuyer William
Proposed Sale
20,000$112.80$2.3M—

View →

Jul 30, 2026Aug 3 8:30 PMAtabak MokariChief Financial Officer
Sale
80,000$114.71$9.2M16,130(D)

View →

Aug 3, 2026Aug 3 4:16 PMLyon Joseph Douglas
Proposed Sale
1,540$114.16$175.8K—

View →

Jul 30, 2026Jul 30 8:03 PMMokari Atabak
Proposed Sale
40,000$114.71$4.6M—

View →

Jul 15, 2026Jul 17 10:38 PMJames N WilsonDirector
Sale
10,000$88.30$883.0K1,084,543(I)

View →

Jul 15, 2026Jul 17 10:31 PMAtabak MokariChief Financial Officer
Sale
40,000$87.71$3.5M16,130(D)

View →

Jul 7, 2026Jul 8 11:54 PMWilliam GuyerChief Development Officer
Sale
20,000$93.13$1.9M3,985(D)

View →

Jul 7, 2026Jul 7 3:12 PMGuyer William
Proposed Sale
20,000$93.13$1.9M—

View →

Jul 1, 2026Jul 6 8:44 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Sale
25,000$88.35$2.2M9,755(D)

View →

Jun 16, 2026Jun 18 8:30 PMJames N WilsonDirector
Sale
10,000$83.20$832.0K1,094,543(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Mar 3 11:16 PMAtabak MokariChief Financial Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:14 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:14 PMHazel HuntChief Scientific Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:13 PMGary Charles RobbChief Business Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:13 PMWilliam GuyerChief Development Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 24, 2026Feb 26 9:45 PMJames N WilsonDirector
Option Exercise
100,000$3.880(D)

View →

Feb 9, 2026Feb 11 10:26 PMHazel HuntChief Scientific Officer
Option Exercise
150,000$3.880(D)

View →

Feb 3, 2026Feb 5 10:42 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65230,000(D)

View →

Jan 27, 2026Jan 29 9:10 PMBAKER G LEONARD JRDirector
Option Exercise
140,000$15.150(D)

View →

← Previous

Page 3 of 3